As U.S. vaccinations speed up, cautious optimism grows
More than 27 million Americans have received a first dose, and more than six million are fully inoculated. — NYT: Top Stories
How are you feeling today? Keep up to date on news and stories related to health care here!
More than 27 million Americans have received a first dose, and more than six million are fully inoculated. — NYT: Top Stories
Here’s a selection of dishes for when the snow has fallen and you’re housebound and hungry. Soups are great. Try warmer meals. — NYT: Top Stories
Amid signs of progress, scientists warned the spread of coronavirus variants must be contained before they become dominant. — NYT: Top Stories
SOMERSET, N.J. — (BUSINESS WIRE) — Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech”), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, announced today that the Committee for Medicinal Products for
Residents in nursing homes have been prioritized as among the first groups to get the vaccine. — NYT: Top Stories
Rich countries are buying up coronavirus vaccines, leaving poorer regions vulnerable — and as potential breeding grounds for variants, like one found in South Africa, that could make vaccines less effective. — NYT: Top Stories
Findings Presented in World Conference on Lung Cancer 2020 Presidential Symposium and Published in the Journal of Clinical Oncology KENILWORTH, N.J. — (BUSINESS WIRE) — $MRK #MRK— Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced first-time data
Friday: Education leaders and teachers have openly criticized the California State’s reopening plan. Parents and legislators are not backing down. — NYT: Top Stories
The Johnson & Johnson’s vaccine’s efficacy rate dropped from 72 percent in the United States to just 57 percent in South Africa, where a highly contagious variant is driving most cases. — NYT: Top Stories